Centrally  	Centrally  	 FW	O
administered  	administered  	 FW	B-NP
isoproterenol  	isoproterenol  	 FW	I-NP
induces  	induces  	 FW	O
sympathetic  	sympathetic  	 FW	B-NP
outflow  	outflow  	 FW	I-NP
via  	via  	 FW	O
brain  	brain  	 FW	B-NP
prostaglandin  	prostaglandin  	 FW	I-NP
E2-mediated  	E2-mediated  	 FW	I-NP
mechanisms  	mechanisms  	 FW	I-NP
in  	in  	 FW	O
rats  	rats  	 FW	O
Brain  	Brain  	 FW	B-NP
β-adrenoceptor  	β-adrenoceptor  	 FW	I-NP
stimulation  	stimulation  	 FW	I-NP
can  	can  	 MD	O
induce  	induce  	 VB	O
elevations  	elevations  	 VBN	O
of  	of  	 IN	O
plasma  	plasma  	 JJ	B-NP
levels  	levels  	 NNS	I-NP
of  	of  	 IN	I-NP
noradrenaline 	noradrenaline 	 NN	I-NP
.  	.  	 .	O
However 	However 	 RB	O
,  	,  	 ,	O
there  	there  	 EX	O
have  	have  	 VBP	O
been  	been  	 VBN	O
no  	no  	 DT	O
detailed  	detailed  	 JJ	O
studies  	studies  	 NNS	O
related  	related  	 VBN	O
to  	to  	 TO	O
signaling  	signaling  	 VB	B-NP
pathways  	pathways  	 JJ	I-NP
downstream  	downstream  	 NN	O
of  	of  	 IN	O
β-adrenoceptors  	β-adrenoceptors  	 JJ	B-NP
responsible  	responsible  	 JJ	O
for  	for  	 IN	O
central  	central  	 JJ	O
sympathetic  	sympathetic  	 JJ	B-NP
outflow 	outflow 	 NN	I-NP
.  	.  	 .	O
In  	In  	 IN	O
the  	the  	 DT	O
present  	present  	 JJ	O
study 	study 	 NN	O
,  	,  	 ,	O
we  	we  	 PRP	O
pharmacologically  	pharmacologically  	 VBP	O
examined  	examined  	 VBN	O
the  	the  	 DT	O
possibility  	possibility  	 NN	O
that  	that  	 WDT	O
centrally  	centrally  	 VBZ	O
administered  	administered  	 VBN	B-NP
isoproterenol  	isoproterenol  	 NNS	I-NP
can  	can  	 MD	O
induce  	induce  	 VB	O
elevations  	elevations  	 VBN	O
of  	of  	 IN	O
plasma  	plasma  	 JJ	B-NP
noradrenaline  	noradrenaline  	 JJ	I-NP
levels  	levels  	 NNS	I-NP
in  	in  	 IN	O
a  	a  	 DT	O
brain  	brain  	 NN	B-NP
prostaglandin-dependent  	prostaglandin-dependent  	 JJ	I-NP
manner 	manner 	 NN	I-NP
.  	.  	 .	O
In  	In  	 IN	O
addition 	addition 	 NN	B-NP
,  	,  	 ,	O
we  	we  	 PRP	O
also  	also  	 RB	O
examined  	examined  	 VBN	O
whether  	whether  	 IN	O
or  	or  	 CC	O
not  	not  	 RB	O
intracerebroventricular  	intracerebroventricular  	 JJ	B-NP
administration  	administration  	 NN	I-NP
of  	of  	 IN	I-NP
isoproterenol  	isoproterenol  	 NNS	I-NP
could  	could  	 MD	O
release  	release  	 VB	O
endogenously  	endogenously  	 FW	O
synthesized  	synthesized  	 FW	B-NP
prostaglandin  	prostaglandin  	 FW	I-NP
( 	( 	 -LRB-	O
PG 	PG 	 NNP	B-NP
)  	)  	 -RRB-	O
E2  	E2  	 CD	O
in  	in  	 IN	O
the  	the  	 DT	O
hypothalamic  	hypothalamic  	 FW	B-NP
paraventricular  	paraventricular  	 FW	I-NP
nucleus  	nucleus  	 FW	I-NP
( 	( 	 -LRB-	O
PVN 	PVN 	 NNP	B-NP
)  	)  	 -RRB-	O
by  	by  	 IN	O
using  	using  	 VBG	O
the  	the  	 DT	O
brain  	brain  	 NN	B-NP
microdialysis  	microdialysis  	 NN	I-NP
technique  	technique  	 NN	I-NP
combined  	combined  	 VBN	O
with  	with  	 IN	O
liquid  	liquid  	 JJ	B-NP
chromatography-ion  	chromatography-ion  	 JJ	I-NP
trap  	trap  	 NN	I-NP
tandem  	tandem  	 NN	I-NP
mass  	mass  	 NN	I-NP
spectrometry  	spectrometry  	 NNS	I-NP
( 	( 	 -LRB-	O
LC-ITMS 	LC-ITMS 	 NNP	B-NP
( 	( 	 -LRB-	I-NP
n 	n 	 LS	I-NP
) 	) 	 -RRB-	O
) 	) 	 -RRB-	O
.  	.  	 .	O
Under  	Under  	 IN	O
urethane  	urethane  	 JJ	O
anesthesia 	anesthesia 	 NN	O
,  	,  	 ,	O
a  	a  	 DT	O
femoral  	femoral  	 JJ	B-NP
venous  	venous  	 JJ	I-NP
line  	line  	 NN	I-NP
was  	was  	 VBD	O
inserted  	inserted  	 VBN	O
for  	for  	 IN	O
infusion  	infusion  	 NN	O
of  	of  	 IN	O
saline  	saline  	 NN	O
and  	and  	 CC	O
a  	a  	 DT	O
femoral  	femoral  	 JJ	B-NP
arterial  	arterial  	 JJ	I-NP
line  	line  	 NN	I-NP
was  	was  	 VBD	O
inserted  	inserted  	 VBN	O
for  	for  	 IN	O
collecting  	collecting  	 VBG	O
blood  	blood  	 NN	O
samples 	samples 	 NNS	O
.  	.  	 .	O
Next 	Next 	 JJ	B-NP
,  	,  	 ,	O
animals  	animals  	 NNS	O
were  	were  	 VBD	O
placed  	placed  	 VBN	O
in  	in  	 IN	O
a  	a  	 DT	O
stereotaxic  	stereotaxic  	 JJ	B-NP
apparatus  	apparatus  	 NN	I-NP
for  	for  	 IN	O
application  	application  	 NN	O
of  	of  	 IN	O
test  	test  	 NN	B-NP
agents 	agents 	 NNS	I-NP
.  	.  	 .	O
Catecholamines  	Catecholamines  	 NNP	B-NP
in  	in  	 IN	O
the  	the  	 DT	O
plasma  	plasma  	 NN	B-NP
were  	were  	 VBD	O
extracted  	extracted  	 VBN	O
by  	by  	 IN	O
alumina  	alumina  	 JJ	B-NP
absorption  	absorption  	 NN	I-NP
and  	and  	 CC	O
were  	were  	 VBD	O
assayed  	assayed  	 VBN	O
by  	by  	 IN	O
high-performance  	high-performance  	 JJ	B-NP
liquid  	liquid  	 JJ	I-NP
chromatography  	chromatography  	 NN	I-NP
with  	with  	 IN	O
electrochemical  	electrochemical  	 JJ	B-NP
detection 	detection 	 NN	I-NP
.  	.  	 .	O
Quantification  	Quantification  	 NNP	B-NP
of  	of  	 IN	I-NP
PGE2  	PGE2  	 CD	I-NP
in  	in  	 IN	O
rat  	rat  	 JJ	B-NP
PVN  	PVN  	 NNP	I-NP
microdialysates  	microdialysates  	 NN	I-NP
was  	was  	 VBD	O
performed  	performed  	 VBN	O
by  	by  	 IN	O
the  	the  	 DT	O
LC-ITMS 	LC-ITMS 	 JJ	B-NP
( 	( 	 -LRB-	I-NP
n 	n 	 LS	I-NP
)  	)  	 -RRB-	I-NP
method 	method 	 NN	I-NP
.  	.  	 .	O
We  	We  	 PRP	O
demonstrated  	demonstrated  	 VBD	O
that  	that  	 IN	O
centrally  	centrally  	 RB	O
administered  	administered  	 VBN	B-NP
isoproterenol-induced  	isoproterenol-induced  	 JJ	I-NP
elevations  	elevations  	 NNS	I-NP
of  	of  	 IN	I-NP
plasma  	plasma  	 JJ	I-NP
noradrenaline  	noradrenaline  	 NN	I-NP
could  	could  	 MD	O
be  	be  	 VB	O
mediated  	mediated  	 VBN	O
via  	via  	 IN	O
activation  	activation  	 NN	B-NP
of  	of  	 IN	I-NP
β-adrenoceptors  	β-adrenoceptors  	 JJ	I-NP
and  	and  	 CC	O
the  	the  	 DT	O
downstream  	downstream  	 FW	O
phospholipase  	phospholipase  	 FW	B-NP
A2-cyclooxygenase  	A2-cyclooxygenase  	 FW	I-NP
pathway 	pathway 	 FW	I-NP
.  	.  	 .	O
Furthermore 	Furthermore 	 RB	O
,  	,  	 ,	O
PGE2  	PGE2  	 NNP	B-NP
in  	in  	 IN	O
the  	the  	 DT	O
PVN  	PVN  	 NNP	B-NP
and  	and  	 CC	O
the  	the  	 DT	O
PGE2  	PGE2  	 CD	B-NP
receptor  	receptor  	 CD	I-NP
EP3  	EP3  	 CD	I-NP
subtype  	subtype  	 NNS	I-NP
appear  	appear  	 VBP	O
to  	to  	 TO	O
play  	play  	 VB	O
an  	an  	 DT	O
important  	important  	 JJ	O
role  	role  	 NN	O
in  	in  	 IN	O
the  	the  	 DT	O
process 	process 	 NN	O
.  	.  	 .	O
Our  	Our  	 PRP$	O
results  	results  	 NNS	O
suggest  	suggest  	 VBP	O
that  	that  	 IN	O
central  	central  	 JJ	O
isoproterenol-induced  	isoproterenol-induced  	 JJ	B-NP
sympathetic  	sympathetic  	 JJ	I-NP
outflow  	outflow  	 NN	I-NP
is  	is  	 VBZ	O
mediated  	mediated  	 VBN	O
via  	via  	 IN	O
brain  	brain  	 NN	B-NP
PGE2  	PGE2  	 NN	I-NP
in  	in  	 IN	O
a  	a  	 DT	O
PGE2  	PGE2  	 CD	B-NP
receptor  	receptor  	 CD	I-NP
EP3  	EP3  	 CD	I-NP
subtype-dependent  	subtype-dependent  	 JJ	I-NP
manner 	manner 	 NN	I-NP
.  	.  	 .	O
